Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2004
03/16/2004US6707038 Providing sample having contiguous surface exhibiting variations in surface characteristic, applying focused radiation to eject droplet of analysis-enhancing fluid from reservoir to deposit droplet on surface at selected site
03/16/2004US6706874 Viral nucleotide sequences for use in the prevention and treatment of viral diseases
03/16/2004US6706873 Nucleic acid molecule encoding specified amino acid sequence
03/16/2004US6706862 Backbone-cyclized BPI peptidomimetics
03/16/2004US6706861 Reconstitution of purified membrane proteins into preformed liposomes
03/16/2004US6706859 HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
03/16/2004US6706762 Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases
03/16/2004US6706687 Platelet-derived growth factor D
03/16/2004US6706686 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
03/16/2004US6706683 Method for controlling the release of granules
03/16/2004US6706539 Apparatus for use in detection of hormones, metabolites, poisons and antigens
03/16/2004US6706536 Method and apparatus for processing coagulation studies, chemistry procedures and the like
03/16/2004US6706531 Placing in receptacle polluted soil or rock sample and predetermined amount of adsorbent material capable of adsorbing part of hydrocarbons to minimize evaporation losses, subjecting to pyrolysis, analyzing hydrocarbons
03/16/2004US6706529 Methods for sequencing proteins
03/16/2004US6706527 Monitoring concentration of prefrential chemical intermediates in soil; obtain sample, insert into monitoring apparatus, determine the concentration of dithionites in soil sample
03/16/2004US6706526 Ethylenediamine tetraacetic acid or derivative, 5-chloro-2-methyl-4-isothiazolin-3-one, 2-methyl-4-isothiazolin-3-one and 5-bromo-5-nitro-1,3-dioxane
03/16/2004US6706520 Assessment of invasive potential of tumor cells
03/16/2004US6706512 Proteolytically activating protein c, free of fibrinogen cleavage activity
03/16/2004US6706508 Isolated polypeptide comprising specified amino acid sequence, which exhibits ornithine carbamoyltransferase activity
03/16/2004US6706506 Detection of epithelial cell cancers and precancerous conditions
03/16/2004US6706497 Methods for producing sialyloligosaccharides in a dairy source
03/16/2004US6706491 Reagents and methods for identifying and modulating expression of genes regulated by p21
03/16/2004US6706490 Contacting biological sample from mammal with antigen comprising cb10 peptide of mammalian type ii collagen or antibody binding fragment, for time and under conditions for antibody-antigen complex to form, detecting complex
03/16/2004US6706488 Antigenic compound for use in the treatment,and diagnosis of cancer
03/16/2004US6706486 Method for the quantitative release of natural or recombinant proteins, polypeptides or peptides
03/16/2004US6706483 Method of identifying and treating invasive carcinomas
03/16/2004US6706482 Conditional-selex
03/16/2004US6706479 Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips
03/16/2004US6706478 Diagnosis of preferential genetic disorders; obtain cell, incubate with probe, detect signal, presence of signal indicates genetic disorders
03/16/2004US6706473 Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
03/16/2004US6706245 Three stage needle for use with an autosampler
03/16/2004US6706232 Biosensor
03/16/2004US6706159 Combined lancet and electrochemical analyte-testing apparatus
03/16/2004US6706094 Collection of dissolved gases from groundwater
03/16/2004US6705983 Compact centrifuge device and use of same
03/16/2004US6705898 Connector for connecting a transmission line to at least one sensor
03/16/2004US6705482 For sealing the open end of blood collection tubes
03/16/2004US6705357 Method and apparatus for gradient generation
03/16/2004CA2438162A1 Biosensor
03/16/2004CA2234204C Novel antibody, renin-active substance containing the same and prorenin assay reagent using the same
03/16/2004CA2139348C Improved chemiluminescent 1,2-dioxetanes
03/16/2004CA2136961C Bnp antibody and immunoassay using it
03/16/2004CA2100709C Method and means for site directed therapy
03/12/2004CA2440550A1 Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays
03/12/2004CA2402963A1 Receptor
03/11/2004WO2004021260A1 A method and a system for detection of malignancy-associated changes
03/11/2004WO2004021248A2 Automated framework for the analysis of biological data
03/11/2004WO2004021242A2 Amino acid sequence pattern matching
03/11/2004WO2004021146A2 Systems and methods for sorting protein sequences and structures for visualization
03/11/2004WO2004021144A2 Systems and methods for inferring biological networks
03/11/2004WO2004021015A1 Method and device for correcting position and posture of object to be held
03/11/2004WO2004021014A2 Cox-2 mediated altered prostaglandin balance in diabetes complications
03/11/2004WO2004021013A1 A method of analysing relative epitope appearance in a plurality of samples
03/11/2004WO2004021012A2 Method of diagnosis of pregnancy-related complications
03/11/2004WO2004021010A2 Method of diagnosing colon and gastric cancers
03/11/2004WO2004021009A2 Methods for detecting endocrine cancer using kallikrein 13 (klk13) as a biomarker
03/11/2004WO2004021008A2 Methods for detecting breast and ovarian cancer
03/11/2004WO2004021007A1 Elisa kits for detecting collagenase 3 as a proenzyme and in an activated form in body fluids and cell culture supernatants
03/11/2004WO2004021006A1 Fluidics-based assay devices
03/11/2004WO2004021005A1 Flow-through assay with an internal calibration system using___ magnetic particles
03/11/2004WO2004021004A1 Membrane-based assays using time-resolved fluorescence
03/11/2004WO2004021003A1 Self-calibration system for a magnetic binding assay
03/11/2004WO2004021002A1 Device and methods for carrying out electrical measurements on membrane bodies
03/11/2004WO2004021001A1 Hydrogel, which can be photostructured in contact exposure and which has linker groups
03/11/2004WO2004021000A1 Immunocapture-based measurements of mammalian pyruvate dehydrogenase complex
03/11/2004WO2004020999A1 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
03/11/2004WO2004020997A1 Optical projection tomography
03/11/2004WO2004020996A1 Optical projection tomography
03/11/2004WO2004020990A1 Silicon seal for microprobes
03/11/2004WO2004020983A2 Ultrafiltration device for drug binding studies
03/11/2004WO2004020982A1 Single phase sampling apparatus and method
03/11/2004WO2004020981A2 Methods of screening cyclic peptides and identifying targets therefor
03/11/2004WO2004020979A2 Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade
03/11/2004WO2004020978A2 Formation of metal nanowires for use as variable-range hydrogen sensors
03/11/2004WO2004020976A2 Diagnostic assay for thrombin-activatable fibrinolysis inhibitor (tafi)
03/11/2004WO2004020973A2 Screening for cell-targeting ligands attached to metal nanoshells for use in target-cell killing
03/11/2004WO2004020970A2 α-AMYLASE ASSAY AND USES THEREOF
03/11/2004WO2004020917A2 Method for identifying thawed and refrozen products
03/11/2004WO2004020674A1 Methods and compositions for functional ubiquitin assays
03/11/2004WO2004020672A1 Targets for type i and type ii diabetes
03/11/2004WO2004020669A1 Method of using nrse and nrsf
03/11/2004WO2004020666A2 Diagnostic and therapeutic use of thyroid hormone binding protein for neurodegenerative diseases
03/11/2004WO2004020665A2 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
03/11/2004WO2004020659A1 Recognition layers made of hydrogel based on polyacrylamide for use in biosensor technology
03/11/2004WO2004020656A1 Culture system, detection and analysis system and detection method for cancer cell colonies
03/11/2004WO2004020655A2 Food pathogen sensor using molecularly imprinted polymers
03/11/2004WO2004020654A2 Solid phase based nucleic acid assays combining high affinity and high specificity
03/11/2004WO2004020653A2 Analytical method for the determination of infant formula protein digestibility in vitro
03/11/2004WO2004020624A1 Cancer antigens and utilization thereof
03/11/2004WO2004020622A1 Methods of quantifying methotrexate metabolites
03/11/2004WO2004020616A1 Method for diagnosing villous tissue atrophy of the small intestine
03/11/2004WO2004020610A2 Methods and compositions for modulating xbp-1 activity
03/11/2004WO2004020597A2 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
03/11/2004WO2004020586A2 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
03/11/2004WO2004020458A2 Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents
03/11/2004WO2004020456A2 Selecting therapeutic human monoclonal antibodies from disease-specific libraries
03/11/2004WO2004020455A2 Genes involved in neuropsychiatric disorders
03/11/2004WO2004020453A2 Functionalized nanoparticles
03/11/2004WO2004020397A1 Standard compound for immunoassay for dioxin and method of immunoassay for dioxin
03/11/2004WO2004020085A1 High density arrays